Direct-Acting Antivirals in the Treatment of Hepatitis C Virus Recurrence after Liver Transplantation: Real-life Experience in a Mexican Cohort

Hepatitis C virus (HCV) infection is one of the most frequent causes of liver transplantation (LT) worldwide. Patients with HCV viremia at the time of LT universally develop recurrent HCV in the allograft, leading to accelerated fibrosis and graft loss. Treatment with direct-acting antivirals (DAA)...

Full description

Saved in:

Bibliographic Details
Published in:	Archives of medical research Vol. 52; no. 7; pp. 713 - 718
Main Authors:	Kauffman-Ortega, Eric, Ruiz-Manriquez, Jesus, Olivas-Martinez, Antonio, Campos-Murguía, Alejandro, Flores-García, Nayelli C, Márquez-Guillén, Ernesto, López-Yáñez, Silvia, Sánchez-Ávila, Francisco, Toapanta-Yanchapaxi, Liz, Paez-Zayas, Victor M, García-Juárez, Ignacio
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.10.2021
Subjects:	Antiviral Agents - therapeutic use Cohort Studies Direct-acting antivirals Hepacivirus - genetics Hepatitis C - drug therapy Hepatitis C virus Hepatitis C, Chronic - drug therapy Humans Liver transplant Liver Transplantation Recurrence Retrospective Studies Treatment Outcome Liver transplant Hepatitis C virus Direct-acting antivirals
ISSN:	0188-4409, 1873-5487, 1873-5487
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!